| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Pain: a review of three commonly used pain rating scales.
|
J Clin Nurs
|
2005
|
5.86
|
|
2
|
Scleritis and episcleritis.
|
Br J Ophthalmol
|
1976
|
3.87
|
|
3
|
Scleritis.
|
Surv Ophthalmol
|
2005
|
3.12
|
|
4
|
Severity of scleritis and episcleritis.
|
Ophthalmology
|
1994
|
2.43
|
|
5
|
Evaluation of patients with scleritis for systemic disease.
|
Ophthalmology
|
2004
|
2.22
|
|
6
|
Targeting melanocortin receptors as a novel strategy to control inflammation.
|
Pharmacol Rev
|
2004
|
2.08
|
|
7
|
High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study.
|
Pediatrics
|
1996
|
2.03
|
|
8
|
Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients.
|
Ophthalmology
|
1999
|
2.02
|
|
9
|
Accuracy of the pain numeric rating scale as a screening test in primary care.
|
J Gen Intern Med
|
2007
|
1.89
|
|
10
|
Clinical characteristics of a large cohort of patients with scleritis and episcleritis.
|
Ophthalmology
|
2011
|
1.85
|
|
11
|
Episcleritis and scleritis: clinical features and treatment results.
|
Am J Ophthalmol
|
2000
|
1.70
|
|
12
|
Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases.
|
Endocr Rev
|
2008
|
1.61
|
|
13
|
Progression of scleral disease.
|
Ophthalmology
|
1991
|
1.59
|
|
14
|
Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents.
|
J Immunol
|
1998
|
1.51
|
|
15
|
Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone.
|
Proc Natl Acad Sci U S A
|
1995
|
1.35
|
|
16
|
Targeting melanocortin receptors as potential novel therapeutics.
|
Pharmacol Ther
|
2006
|
1.23
|
|
17
|
Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
|
Am J Nephrol
|
2012
|
1.22
|
|
18
|
Scleritis associated with systemic vasculitic diseases.
|
Ophthalmology
|
1995
|
1.22
|
|
19
|
The melanocortin system in control of inflammation.
|
ScientificWorldJournal
|
2010
|
1.14
|
|
20
|
Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series.
|
Drug Des Devel Ther
|
2012
|
1.12
|
|
21
|
A standardized grading system for scleritis.
|
Ophthalmology
|
2010
|
1.03
|
|
22
|
A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.
|
Nephrol Dial Transplant
|
2014
|
1.02
|
|
23
|
ACTH is a potent regulator of gene expression in human adrenal cells.
|
J Mol Endocrinol
|
2010
|
0.99
|
|
24
|
Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis.
|
Am J Ophthalmol
|
2008
|
0.91
|
|
25
|
ACTH: The forgotten therapy.
|
Semin Immunol
|
2015
|
0.90
|
|
26
|
Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial.
|
Drug Des Devel Ther
|
2011
|
0.89
|
|
27
|
Treatment of moderately to severely active systemic lupus erythematosus with adrenocorticotropic hormone: a single-site, open-label trial.
|
Lupus
|
2014
|
0.86
|
|
28
|
Clinical features and visual outcomes of Japanese patients with scleritis.
|
Br J Ophthalmol
|
2010
|
0.84
|
|
29
|
Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice.
|
J Immunol
|
2013
|
0.84
|
|
30
|
Scleritis and systemic disease association in a community-based referral practice.
|
Am J Ophthalmol
|
2009
|
0.82
|
|
31
|
Following EAU recovery there is an associated MC5r-dependent APC induction of regulatory immunity in the spleen.
|
Invest Ophthalmol Vis Sci
|
2011
|
0.82
|
|
32
|
Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey.
|
Cornea
|
2010
|
0.82
|
|
33
|
Treatment of chronic, noninfectious, nonnecrotizing scleritis with tumor necrosis factor alpha inhibitors.
|
Ocul Immunol Inflamm
|
2013
|
0.82
|
|
34
|
Autocrine alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation in human glioma.
|
J Neurosci Res
|
1999
|
0.78
|
|
35
|
Direct effects of HP Acthar Gel on human B lymphocyte activation in vitro.
|
Arthritis Res Ther
|
2015
|
0.78
|
|
36
|
Complete Remission of Post-transplantation Recurrence of Focal Segmental Glomerulosclerosis With the Use of Adrenocorticotrophic Hormone Gel: Case Report.
|
Transplant Proc
|
2015
|
0.77
|
|
37
|
Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis.
|
Ocul Immunol Inflamm
|
2012
|
0.77
|
|
38
|
Cyclo-oxygenase inhibitors in the treatment of chronic non-infectious, non-necrotizing scleritis and episcleritis.
|
Ocul Immunol Inflamm
|
2012
|
0.75
|